Literature DB >> 17875943

Epigenetic control of the immune escape mechanisms in malignant carcinomas.

A Francesca Setiadi1, Muriel D David, Robyn P Seipp, Jennifer A Hartikainen, Rayshad Gopaul, Wilfred A Jefferies.   

Abstract

Downregulation of the transporter associated with antigen processing 1 (TAP-1) has been observed in many tumors and is closely associated with tumor immunoevasion mechanisms, growth, and metastatic ability. The molecular mechanisms underlying the relatively low level of transcription of the tap-1 gene in cancer cells are largely unexplained. In this study, we tested the hypothesis that epigenetic regulation plays a fundamental role in controlling tumor antigen processing and immune escape mechanisms. We found that the lack of TAP-1 transcription in TAP-deficient cells correlated with low levels of recruitment of the histone acetyltransferase, CBP, to the TAP-1 promoter. This results in lower levels of histone H3 acetylation at the TAP-1 promoter, leading to a decrease in accessibility of the RNA polymerase II complex to the TAP-1 promoter. These observations suggest that CBP-mediated histone H3 acetylation normally relaxes the chromatin structure around the TAP-1 promoter region, allowing transcription. In addition, we found a hitherto-unknown mechanism wherein interferon gamma up-regulates TAP-1 expression by increasing histone H3 acetylation at the TAP-1 promoter locus. These findings lie at the heart of understanding immune escape mechanisms in tumors and suggest that the reversal of epigenetic codes may provide novel immunotherapeutic paradigms for intervention in cancer.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17875943      PMCID: PMC2169144          DOI: 10.1128/MCB.01547-07

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  31 in total

Review 1.  Histone acetylation and chromatin remodeling.

Authors:  P D Gregory; K Wagner; W Hörz
Journal:  Exp Cell Res       Date:  2001-05-01       Impact factor: 3.905

Review 2.  Control of histone modifications.

Authors:  J R Davie; V A Spencer
Journal:  J Cell Biochem       Date:  1999       Impact factor: 4.429

Review 3.  Histone acetylation: a switch between repressive and permissive chromatin. Second in review series on chromatin dynamics.

Authors:  Anton Eberharter; Peter B Becker
Journal:  EMBO Rep       Date:  2002-03       Impact factor: 8.807

4.  Coordinate downregulation of multiple MHC class I antigen processing genes in chemical-induced murine tumor cell lines of distinct origin.

Authors:  B Seliger; U Wollscheid; F Momburg; T Blankenstein; C Huber
Journal:  Tissue Antigens       Date:  2000-10

Review 5.  Dynamic chromatin: concerted nucleosome remodelling and acetylation.

Authors:  Anton Eberharter; Roger Ferreira; Peter Becker
Journal:  Biol Chem       Date:  2005-08       Impact factor: 3.915

6.  TAP expression provides a general method for improving the recognition of malignant cells in vivo.

Authors:  J Alimonti; Q J Zhang; R Gabathuler; G Reid; S S Chen; W A Jefferies
Journal:  Nat Biotechnol       Date:  2000-05       Impact factor: 54.908

Review 7.  The transporter associated with antigen processing (TAP): structural integrity, expression, function, and its clinical relevance.

Authors:  U Ritz; B Seliger
Journal:  Mol Med       Date:  2001-03       Impact factor: 6.354

Review 8.  Antigen-processing machinery breakdown and tumor growth.

Authors:  B Seliger; M J Maeurer; S Ferrone
Journal:  Immunol Today       Date:  2000-09

9.  Functional interaction of STAT3 transcription factor with the coactivator NcoA/SRC1a.

Authors:  Sandrine Giraud; Frédéric Bienvenu; Sylvie Avril; Hugues Gascan; David M Heery; Olivier Coqueret
Journal:  J Biol Chem       Date:  2001-12-31       Impact factor: 5.157

Review 10.  The transporter associated with antigen processing: function and implications in human diseases.

Authors:  Brigitte Lankat-Buttgereit; Robert Tampé
Journal:  Physiol Rev       Date:  2002-01       Impact factor: 37.312

View more
  25 in total

1.  Identification of E2F1 as an important transcription factor for the regulation of tapasin expression.

Authors:  Juergen Bukur; Felix Herrmann; Diana Handke; Christian Recktenwald; Barbara Seliger
Journal:  J Biol Chem       Date:  2010-07-27       Impact factor: 5.157

2.  Perspective: Flicking with flow: Can microfluidics revolutionize the cancer research?

Authors:  Tamal Das; Suman Chakraborty
Journal:  Biomicrofluidics       Date:  2013-01-31       Impact factor: 2.800

3.  Effect of 5-aza-2'-deoxycytidine on immune-associated proteins in exosomes from hepatoma.

Authors:  Wen-Hua Xiao; Gao-Wa Sanren; Jian-Hua Zhu; Qiu-Wen Li; Huan-Rong Kang; Ru-Liang Wang; Lin-Ping Song; Ming Ye
Journal:  World J Gastroenterol       Date:  2010-05-21       Impact factor: 5.742

Review 4.  Marked for death: targeting epigenetic changes in cancer.

Authors:  Sophia Xiao Pfister; Alan Ashworth
Journal:  Nat Rev Drug Discov       Date:  2017-03-10       Impact factor: 84.694

Review 5.  Tumour-associated antigens: considerations for their use in tumour immunotherapy.

Authors:  Adam J Linley; Murrium Ahmad; Robert C Rees
Journal:  Int J Hematol       Date:  2011-03-01       Impact factor: 2.490

Review 6.  Epigenetic mechanisms of tumor resistance to immunotherapy.

Authors:  Natalia Arenas-Ramirez; Dilara Sahin; Onur Boyman
Journal:  Cell Mol Life Sci       Date:  2018-08-23       Impact factor: 9.261

Review 7.  HLA antigen changes in malignant cells: epigenetic mechanisms and biologic significance.

Authors:  M Campoli; S Ferrone
Journal:  Oncogene       Date:  2008-10-06       Impact factor: 9.867

8.  Immunotherapy augments the effect of 5-azacytidine on HPV16-associated tumours with different MHC class I-expression status.

Authors:  J Símová; V Polláková; M Indrová; R Mikyšková; J Bieblová; I Stěpánek; J Bubeník; M Reiniš
Journal:  Br J Cancer       Date:  2011-10-20       Impact factor: 7.640

Review 9.  Exploiting tumor epigenetics to improve oncolytic virotherapy.

Authors:  Nicole E Forbes; Hesham Abdelbary; Mathieu Lupien; John C Bell; Jean-Simon Diallo
Journal:  Front Genet       Date:  2013-09-20       Impact factor: 4.599

10.  Role of gene methylation in antitumor immune response: implication for tumor progression.

Authors:  Alfonso Serrano; Isabel Castro-Vega; Maximino Redondo
Journal:  Cancers (Basel)       Date:  2011-03-29       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.